HBeAg阴性慢性乙型肝炎研究进展

郑自华; 张立伐

HBeAg阴性慢性乙型肝炎研究进展

详细信息

中图分类号: R512.62
计量
- 文章访问数: 1817
- HTML全文浏览量: 4
- PDF下载量: 839
- 被引次数: 0
出版历程
- 出版日期: 2007-01-20

摘要

HTML全文

参考文献(17)

[1]World Health Organization.Hepatitis B[DB].World Health Organi-zation Fact Sheet204. (Revised October2000) .WHO website.ht-tp://www.who.int/mediacentre/factsheets/fs204/en.

[2]Hadziyannis SJ, Vassilopoulos D.Hepatitis B e antigen-negativechronic hepatitis B[J].Hepatology, 2001, 34 (4) ∶617-624.

[3]Fattovich G.Natural history of hepatitis B[J].J Hepatol, 2003, 39suppl 1∶S50-S58.

[4]雷春亮, 彭晓谋, 顾林, 等.HBeAg阴性慢性乙型肝炎患者出现前C区和基本核启动子联合突变的意义[J].中华传染病杂志, 2005, 23 (1) ∶10-13.

[5]Liaw YF, Leng N, Guan R, et al.Asian-Pacific consensus state-ment on the management of chronic hepatitis B:a 2005 update[J].Liver Int, 2005, 25∶472-489.

[6]Funk ML, Rosenberg DM, Lok ASF.Word-wide epidemiology ofHBeAg-negative chronic hepatitis B and associated precore and coreprmoter variants[J].J Viral Hepat, 2002, 9∶52-61.

[7]任红.中国慢性乙型肝炎治疗策略—2004年全国乙型肝炎治疗策略专家峰会纪要[J].中华肝脏病杂志, 2005, 13 (5) ∶326-328.

[8]Bonino F, Brunetto MR.Chronic hepatitis B e antigen (HBeAg) negative, anti-HBe positive hepatitis B:an overview[J].J Hepatol, 2003, 39 suppl 1∶S160-S163.

[9] 骆抗先.乙型肝炎基础和临床[M].第2版.北京:人民卫生出版社, 2001∶274.

[10]Papatheodoridis GV, Hadziyannis SJ.Diagnosis and management ofpre-core mutant chronic hepatitis B[J].J Viral Hepat, 2001, 8, 311-321.

[11]Anna SF, Lok and Brian J.McMahon.Chronic Hepatitis B:Up-date of Recommendations[J].AASLD PRACTICE GUIDELINE.Hepatology, 2004, 39 (3) ∶857-861.

[12]de Franchis R, Hadengue A.ESALinternational Consensus Confer-ence on Hepatitis B[J].J Hepatol, 2003, 39 suppl 1∶s3-s25.

[13]贾继东.乙型肝炎e抗原阴性慢性乙型肝炎的治疗[J].中华肝脏病杂志, 2005, 13 (7) ∶539.

[14]Lin CC, Wu JC, Chang TT, et al.Long-termevaluation of recom-binant interferon alpha2b in the treatment of patients with hepatitis Be antigen-negative chronic hepatitis B in Taiwan[J].J Viral Hepat, 2001, 8∶438-446.

[15]Manesis E K, Hadziyannis S J.Interferon alpha treatment and re-treatment of hepatitis B e antigen negative chronic hepatitis B mutants[J].Gastroenterology, 2001, 121∶101-109.

[16]Marcellin P, Lau GKK, Bonino F, et al.Peginterferon alfa-2a a-lone, lamivudine alone and the two in combination in patients withHBeAg negative chronic hepatitis B[J].NEngl J Med, 2004, 351∶1206-1217.

[17]Lai CL, Rosmawati M, Lao J, et al.Entecavir is superior to lami-vudine in reducing hepatitis B virus DNA in patients with chronichepatitis B infection[J].Gastroenterology, 2002, 123 (6) ∶1831~1838.

施引文献

资源附件(0)

访问统计